The anticancer effect of the <scp>HDAC</scp> inhibitor belinostat is enhanced by inhibitors of Bcl‐ <scp> x <sub>L</sub> </scp> or Mcl‐1 in ovarian cancerCécilia Thomine, Marie Villedieu|Molecular Oncology|2025Cited by 3